335 related articles for article (PubMed ID: 10955775)
1. C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers.
Wang L; Lin SH; Wu WG; Kemp BL; Walsh GL; Hong WK; Mao L
Clin Cancer Res; 2000 Aug; 6(8):2988-93. PubMed ID: 10955775
[TBL] [Abstract][Full Text] [Related]
2. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
[TBL] [Abstract][Full Text] [Related]
3. Function and therapeutic implication of C-CAM cell-adhesion molecule in prostate cancer.
Lin SH; Pu YS
Semin Oncol; 1999 Apr; 26(2):227-33. PubMed ID: 10597733
[TBL] [Abstract][Full Text] [Related]
4. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer.
Wu W; Kemp BL; Proctor ML; Gazdar AF; Minna JD; Hong WK; Mao L
Cancer Res; 1999 Apr; 59(8):1846-51. PubMed ID: 10213490
[TBL] [Abstract][Full Text] [Related]
5. Association of an 80 kDa protein with C-CAM1 cytoplasmic domain correlates with C-CAM1-mediated growth inhibition.
Luo W; Earley K; Tantingco V; Hixson DC; Liang TC; Lin SH
Oncogene; 1998 Mar; 16(9):1141-7. PubMed ID: 9528856
[TBL] [Abstract][Full Text] [Related]
6. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F
Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551
[TBL] [Abstract][Full Text] [Related]
7. Expression and androgen regulation of C-CAM cell adhesion molecule isoforms in rat dorsal and ventral prostate.
Makarovskiy AN; Pu YS; Lo P; Earley K; Paglia M; Hixson DC; Lin SH
Oncogene; 1999 May; 18(21):3252-60. PubMed ID: 10359531
[TBL] [Abstract][Full Text] [Related]
8. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF
Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090
[TBL] [Abstract][Full Text] [Related]
9. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
10. The cytoplasmic domain is critical to the tumor suppressor activity of TSLC1 in non-small cell lung cancer.
Mao X; Seidlitz E; Ghosh K; Murakami Y; Ghosh HP
Cancer Res; 2003 Nov; 63(22):7979-85. PubMed ID: 14633730
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP
Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
[TBL] [Abstract][Full Text] [Related]
13. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
[TBL] [Abstract][Full Text] [Related]
14. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.
Hayashi M; Tokuchi Y; Hashimoto T; Hayashi S; Nishida K; Ishikawa Y; Nakagawa K; Tsuchiya S; Okumura S; Tsuchiya E
Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800
[TBL] [Abstract][Full Text] [Related]
15. Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility.
Salgia R; Li JL; Ewaniuk DS; Wang YB; Sattler M; Chen WC; Richards W; Pisick E; Shapiro GI; Rollins BJ; Chen LB; Griffin JD; Sugarbaker DJ
Oncogene; 1999 Jan; 18(1):67-77. PubMed ID: 9926921
[TBL] [Abstract][Full Text] [Related]
16. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
[TBL] [Abstract][Full Text] [Related]
17. The cytoplasmic domain of C-CAM1 tumor suppressor is necessary and sufficient for suppressing the tumorigenicity of prostate cancer cells.
Estrera VT; Luo W; Phan D; Earley K; Hixson DC; Lin SH
Biochem Biophys Res Commun; 1999 Oct; 263(3):797-803. PubMed ID: 10512760
[TBL] [Abstract][Full Text] [Related]
18. A candidate tumor suppressor gene, H37, from the human lung cancer tumor suppressor locus 3p21.3.
Oh JJ; West AR; Fishbein MC; Slamon DJ
Cancer Res; 2002 Jun; 62(11):3207-13. PubMed ID: 12036935
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.
Sunahara M; Shishikura T; Takahashi M; Todo S; Yamamoto N; Kimura H; Kato S; Ishioka C; Ikawa S; Ikawa Y; Nakagawara A
Oncogene; 1999 Jun; 18(25):3761-5. PubMed ID: 10391684
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
